Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,838,977
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
6,135,684
-
Shares change
-
+98,238
-
Total reported value, excl. options
-
$60,069,000
-
Value change
-
+$1,306,232
-
Number of buys
-
17
-
Number of sells
-
20
-
Price
-
$9.79
Institutional Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q1 2019
As of 31 Mar 2019 CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,135,684 shares of stock of the company.
Largest 10 holders included Battery Partners IX, LLC, NEA Management Company, LLC, CADENCE CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Granite Investment Partners, LLC, RENAISSANCE TECHNOLOGIES LLC, PERKINS CAPITAL MANAGEMENT INC, INGALLS & SNYDER LLC, DIMENSIONAL FUND ADVISORS LP, and Schonfeld Strategic Advisors LLC.
This table shows 47 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.